Oncology (Williston Park, N.Y.)

publication venue for

The Immunocompromised Traveler. 2016
Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer. 2014
NCCN Practice Guidelines for Acute Myelogenous Leukemia. 2000
NCCN Practice Guidelines for Breast Cancer. 2000
NCCN Practice Guidelines for Cancer-Related Fatigue. 2000
NCCN Practice Guidelines for Chronic Myelogenous Leukemia. 2000
NCCN Practice Guidelines for Head and Neck Cancers. 2000
NCCN Practice Guidelines for Prostate Cancer. 2000
NCCN practice guidelines for Hodgkin's disease. National Comprehensive Cancer Network. 1999
NCCN practice guidelines for fever and neutropenia. National Comprehensive Cancer Network. 1999
Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network. 1999
NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network. 1998
NCCN practice guidelines for multiple myeloma. National Comprehensive Cancer Network. 1998
NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network. 1998
NCCN practice guidelines for testicular cancer. National Comprehensive Cancer Network. 1998
NCCN practice guidelines for upper gastrointestinal carcinomas. National Comprehensive Cancer Network. 1998
NCCN melanoma practice guidelines. National Comprehensive Cancer Network. 1998
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. 1998
NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. 1998
Society of Surgical Oncology practice guidelines. Melanoma surgical practice guidelines. 1997
Society of Surgical Oncology practice guidelines. Soft-tissue sarcoma surgical practice guidelines. 1997
Colorectal cancer surgical practice guidelines. Colorectal Cancer Practice Guideline Committee. 1997
Breast cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines. 1997
NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. 1996
NCCN Acute Leukemia Practice Guidelines. The National Comprehensive Cancer Network. 1996
NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network. 1996
NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network. 1996
Sharing Serious News With Cancer Patients: Strategies That Can Help.. 32. 2018
Diagnosing and Managing Delirium in Cancer Patients.. 31. 2017
Point/Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer.. 31. 2017
Low-Grade Serous Carcinoma of the Ovary.. 30. 2016
COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?. 30. 2016
Diabetes Management in Cancer Patients.. 30. 2016
Chemotherapy-Induced Peripheral Neuropathy.. 30. 2016
When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women.. 30. 2016
Obesity and Metabolic Disease After Childhood Cancer.. 29. 2015
Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and Challenges.. 29. 2015
Fertility Preservation in Patients With Cervical Cancer.. 29. 2015
Is classical stereotactic radiotherapy the optimal partner for immunotherapy?. 29. 2015
Management of metastatic colorectal cancer.. 28. 2014
Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach?. 27. 2013
Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplant.. 24. 2010
Clinical management of EGFRI dermatologic toxicities: US perspective.. 21. 2007
Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae.. 21. 2007
Improving adherence to endocrine therapies: the role of advanced practice nurses.. 20. 2006
Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.. 18. 2004
Irinotecan in esophageal cancer.. 17. 2003
Stress and burnout in oncology.. 14. 2000
Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.. 14. 2000
Management of renal cell carcinoma.. 14. 2000
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect.. 13. 1999
One-hour paclitaxel via weekly infusion: dose-density with enhanced therapeutic index.. 12. 1998
Implementation of practice guidelines.. 11. 1997
NCCN adult brain tumor practice guidelines.. 11. 1997
NCCN antiemesis practice guidelines.. 11. 1997
NCCN preliminary non-Hodgkin's lymphoma practice guidelines.. 11. 1997
Update of the NCCN guidelines for treatment of breast cancer.. 11. 1997
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer.. 11. 1997
Comentary (Steinherz): Toxicity of CNS Prophylaxis for Childhood Leukemia.. 11. 1997
Development and implementation of clinical management guidelines.. 10. 1996
Outcomes research studies.. 10. 1996
Current management of lobular carcinoma in situ of the breast.. 8. 1994
Current status of larynx preservation with multimodality therapy.. 6. 1992
Cervical lymph node metastases--diagnostic, therapeutic, and prognostic implications.. 4. 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials.. 4. 1990
Silvia Formenti on the promise of combining radiotherapy and immunotherapy to treat cancer.. 30. 2016
Long-term effects of chemo on the cognitive function of cancer patients.. 26. 2012
Therapy for Peripheral T-Cell Lymphomas: Where We Are and Where We Hope to Be. 2015
PET imaging and breast cancer. 2014
Surgical breast oncologists: successful innovators and patient advocates. 2014
Addressing the challenge of managing radiation use in medical imaging: paradigm shifts and strategic priorities. 2014
Treatment of metastatic pancreatic adenocarcinoma: new options and promising strategies. 2014
More on facing the reality of our aging population with breast cancer. 2012
Brain metastasis in breast cancer: last barrier to the cure? 2012
Splenic lymphomas: is there still a role for splenectomy? 2012
Are we trumping bone disease in prostate cancer? 2011
Bladder cancer treatment: optimize, don't compromise. 2011
Patients with H pylori-independent MALT lymphoma are curable with radiotherapy. 2011
Consider thrombotic microangiopathy in pediatric and hematopoietic stem cell transplant patients. 2011
Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities. 2011
Anthracyclines are a critical component of adjuvant chemotherapy regimens for high-risk early breast cancer. 2011
Seeing red: anthracyclines for breast cancer. 2011
Cancer stem cells, EMT, and seeding: a rose is a rose is a rose? 2011
Improving the therapeutic benefits of ipilimumab. 2010
Pancreatic adenocarcinoma: new approaches to a challenging malignancy. 2010
Preoperative therapy in esophageal cancer: controversy and consensus. 2010
The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization. 2010
Lung cancer in 'Never-smokers': molecular factors trump risk factors. 2010
Update on eltrombopag for ITP. 2009
Changing management strategies for hepatic colorectal metastasis. 2009
Testicular granulosa cell tumors: rare tumors need to be studied too. 2009
Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients? 2009
How should we care for elderly cancer patients? 2009
The growing importance of skin toxicity in EGFR inhibitor therapy. 2009
Management of early ovarian cancer. 2004
More on the treatment of anal margin carcinomas. 1997
The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval.. 31. 2017
DLBCL Cell of Origin: What Role Should It Play in Care Today? 2018
Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 2: Existing Experience and Considerations for Future Trials. 2018
Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment. 2018
Optimizing Treatment Approaches in Advanced Renal Cancer. 2017
Decision Making in the Surgical Management of Invasive Breast Cancer-Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy. 2017
Decision Making in the Surgical Management of Invasive Breast Cancer-Part 2: Expanded Applications for Breast-Conserving Surgery. 2017
Next Generation of Targeted Molecules for Non-Hodgkin Lymphomas: Small-Molecule Inhibitors of Intracellular Targets and Signaling Pathways. 2016
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach. 2016
Is Personalized Medicine Here? 2016
Immunotherapy: New Strategies for the Treatment of Gynecologic Malignancies. 2016
Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers. 2016
Clinical Issues in the Surgical Management of Screen-Identified Lung Cancers. 2015
Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression. 2015
Screening and Prevention of Hepatitis B Virus Reactivation During Chemotherapy. 2015
Intraoperative Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer. 2015
Cancer stem cells: implications for cancer therapy. 2014
CTLA-4 antibodies: new directions, new combinations. 2014
Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer. 2014
Management of the clinically node-negative axilla: what have we learned from the clinical trials? 2014
Acr appropriateness Criteria management of vaginal cancer. 2013
Provocative pearls in diagnosing and treating acute promyelocytic leukemia. 2012
Genetic testing in gastrointestinal cancers: a case-based approach. 2012
Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy. 2011
Inflammatory breast cancer: what progress have we made? 2011
Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target? 2010
Genome-wide association studies of cancer: principles and potential utility. 2010
HER2-positive breast cancer: beyond trastuzumab. 2010
Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. 2010
Management of relapsed mantle cell lymphoma: still a treatment challenge. 2009
Bevacizumab in the treatment of metastatic breast cancer. 2009
Anthracycline cardiotoxicity after breast cancer treatment. 2009
What is the optimal treatment of localized pancreatic adenocarcinoma? 2008
Stereotactic body radiotherapy in the management of painful bone metastases. 2008
New therapeutic options in gastrointestinal stromal tumors. 2008
Dermatologic challenges in cancer patients and survivors. 2007
MRI and breast cancer: role in detection, diagnosis, and staging. 2007
Clinical presentation and pathophysiology of EGFRI dermatologic toxicities. 2007
What progress have we made in managing inflammatory breast cancer? 2007
Reproductive issues in the gynecologic cancer patient. 2007
Emerging role of immunotherapy in the management of prostate cancer. 2007
Novel targets and therapies for metastatic renal cell carcinoma. 2006
Management of liver metastases from colorectal cancer. 2006
Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. 2006
Systemic treatment of breast cancer. Two decades of progress. 2006
Radiation therapy in the management of brain metastases from renal cell carcinoma. 2006
EGFR inhibitors in lung cancer. 2005
Psychiatric assessment and symptom management in elderly cancer patients. 2005
Metastatic colorectal cancer: is there one standard approach? 2005
Emerging targeted therapies for breast cancer. 2005
Infectious complications of lung cancer. 2005
Gemcitabine and docetaxel in metastatic breast cancer. 2004
Delirium in palliative care. 2004
Depression in cancer patients. 2004
The role of neck dissection following definitive chemoradiation. 2004
Surgical cytoreduction in ovarian cancer. 2004
Management of early ovarian cancer. 2004
Ductal lavage: what we know and what we don't. 2004
Introduction. Single-agent or combination chemotherapy in metastatic breast cancer. 2003
Erlotinib: preclinical investigations. 2003
Risk models for chemotherapy-induced neutropenia in non-Hodgkin's lymphoma. 2003
Risk models for neutropenia in patients with breast cancer. 2003
Cervical cancer: issues of sexuality and fertility. 2003
Prophylactic surgery in hereditary breast/ovarian cancer syndrome. 2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications. 2003
Pancreatic cancer: epidemiology, genetics, and approaches to screening. 2002
HER2 testing and correlation with efficacy of trastuzumab therapy. 2002
Prostate-specific antigen as a marker of disease activity in prostate cancer. 2002
Prostate-specific antigen as a marker of disease activity in prostate cancer. 2002
Current perspectives on pain in AIDS. 2002
Current perspectives on pain in AIDS. 2002
Irinotecan, cisplatin, and radiation in esophageal cancer. 2002
Potential role of selective COX-2 inhibitors in cancer management. 2002
Cisplatin and irinotecan in upper gastrointestinal malignancies. 2001
Gemcitabine as single-agent therapy in the management of advanced breast cancer. 2001
Oral chemotherapy for colorectal cancer: some economic considerations. 2001
Perspectives on fluorinated pyrimidine use in gastrointestinal and breast oncology. 2001
Irinotecan in esophageal cancer. 2000
Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer. 2000
Contribution of anemia to fatigue in the cancer patient. 2000
Screening for ovarian cancer: what we know, what we need to know. 2000
Changing patterns of infections and antimicrobial susceptibilities. 2000
An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. 2000
Update on the management of primary CNS lymphoma. 2000
Paclitaxel in the treatment of advanced urothelial cancer. 2000
Radiotherapy in the management of plasma cell tumors. 2000
Diagnosis and treatment of depression in cancer patients. 1999
Malignant mesothelioma of the pleural space. 1999
Laparoscopy in gynecologic malignancies. 1999
Update on the management of advanced breast cancer. 1999
Sentinel lymph node mapping in breast cancer. 1999
Progress toward guidelines for the management of fatigue. 1998
Hepatic colorectal metastasis: current status of surgical therapy. 1998
Role of laparoscopy in the staging of gastrointestinal cancer. 1998
Irinotecan and cisplatin in upper gastrointestinal malignancies. 1998
Irinotecan in the first-line treatment of colorectal cancer. 1998
Salvage therapy for ovarian cancer. 1998
Stereotactic breast biopsy: indications and results. 1998
Biology and treatment of malignant glioma. 1998
Combined-modality therapy for bladder cancer. 1997
The Prostate Cancer Intervention Versus Observation Trial (PIVOT). 1997
HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. 1997
Paclitaxel for breast cancer: the Memorial Sloan-Kettering Cancer Center experience. 1997
Management of esophageal cancer. 1996
BCG immunotherapy for transitional-cell carcinoma in situ of the bladder. 1995
Role of laparoscopic techniques in colorectal cancer surgery. 1995
Current combined treatment of high-grade osteosarcomas. 1995
Current management of primary central nervous system lymphoma. 1995
Percutaneous endoscopic stomas for enteral feeding and drainage. 1995
Adjuvant postoperative therapy of gastrointestinal malignancies. 1994
A review of idarubicin in acute leukemia. 1993
Neoadjuvant therapy for gastrointestinal cancers. 1993
Autoimmune disease and silicone breast implants. 1993
Management of nausea and vomiting caused by anticancer drugs: state of the art. 1992
Chemotherapy as part of the initial treatment for nasopharyngeal cancer. 1991
Radiotherapy vs intrathecal chemotherapy for CNS prophylaxis in childhood ALL. 1989
Primary CNS lymphoma: managing patients with spontaneous and AIDS-related disease. 1987
Current status of chemotherapy for urothelial tract tumors. 1987
Current status of antitumor therapy with monoclonal antibodies. 1987
Suicide in cancer patients. 1987

VIVO Weill Cornell Medical College

Oncology (Williston Park, N.Y.) Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)